PRJNA765129
CRISPR/Cas9 knockout screen in SH-SY5Y using ALK inhibitors
A CRISPR/Cas9 knockout screen was performed in SH-SY5Y using the ALK inhibitors Lorlatinib and Ceritinib to identify genes associated with ALK inhibitor resistance in neuroblastoma.